Preços de fertilização in vitro (fiv) em Portugal: updated price in Portugal

The figures shown reflect average prices charged by private centres licensed by the CNPMA. The base price typically includes initial consultations, ultrasound monitoring, the clinical procedure and embryology. Hormonal medication is almost always billed separately and can add €800–€1,500 per cycle, depending on the stimulation protocol and ovarian response. In Viana Do Castelo, the private offer is more concentrated than in other regions, so prices tend to align with the national average within a ±15% range. Approximate GBP/USD conversions: €1 ≈ £0.86 ≈ $1.08.

In Portugal, the SNS covers MAP treatments at authorised public centres under Law 32/2006. Eligibility criteria include: woman up to 40 at the start of treatment, GP or SNS gynaecologist referral, no common children of the couple and compliance with the protocols defined by the DGS. SNS access is free, with an average waiting time of 12 to 24 months. In the private sector, treatment usually begins 2 to 6 weeks after the first appointment.

Usually included in the base price: initial medical consultation, monitoring ultrasounds during the cycle, theatre time, anaesthesia (where applicable), embryology laboratory, first embryo transfer. Usually not included: hormonal stimulation medication, additional investigations (semen analysis, detailed hormonal panel, hysterosalpingography), add-ons such as ICSI, PGT-A/PGT-M, assisted hatching, embryo vitrification and annual storage. Before committing to any centre, request a written quote that itemises every line and states the expected number of cycles in the treatment plan.

Beyond price, three criteria determine the quality of a fertility centre: the clinical team (multidisciplinary, registered with the Portuguese Medical Association and trained specifically in reproductive medicine), transparency (publication of age-stratified success rates as reported to CNPMA) and laboratory infrastructure (time-lapse incubators, air-quality control, ISO certifications). ESHRE publishes good-practice recommendations that serve as an editorial reference. We recommend requesting three parallel quotes to compare in a structured, pressure-free way.

Female age is the strongest prognostic variable in reproductive medicine, and preços de fertilização in vitro (fiv) em portugal is no exception. Annual reports from CNPMA and the European IVF Monitoring Consortium (EIM/ESHRE) show a steady decline with age: under 35, clinical pregnancy rates per transfer range from 30% to 45%; between 36 and 39 they fall to 20–30%; over 40 they sit between 5% and 15%. AMH and antral follicle count refine the individual prognosis but do not replace age as the dominant variable. In practical terms this means three things: (1) start the diagnostic workup early, even without a perceived urgency; (2) discuss fertility preservation between 30 and 35 when no pregnancy project is on the table; (3) ask the centre for age-stratified outcomes — not the global average, which is misleading.

International good practice, echoed by ESHRE and the UK's HFEA, recommends preparing concrete questions for the first consultation. For preços de fertilização in vitro (fiv) em portugal, ask: (1) What is my prognosis for my age group, based on this centre's CNPMA-reported numbers? (2) How many cycles are likely needed and what is the realistic total cost, medication and add-ons included? (3) Which protocol do you recommend and why — long agonist, antagonist, mild stimulation? (4) What is your transfer policy — elective single embryo or multiple — and what are your twin rates? (5) What happens to surplus embryos and what are the annual vitrification fees? (6) What is the plan if this cycle fails — same protocol or change? Documenting answers and comparing them across clinics is one of the most effective forms of informed consent.

Several myths persist in the public space. Myth 1: "More cycles always means better outcomes" — most cumulative success occurs in the first three cycles; ESHRE recommends reassessing protocol after two failed cycles. Myth 2: "Clinics with higher headline rates are the best" — clinics selecting easier cases publish better numbers; what matters is age- and diagnosis-stratified outcomes. Myth 3: "Public (SNS) care is inferior to private" — Portuguese public centres are staffed by equally qualified teams using certified laboratories; the real difference is waiting time and scheduling flexibility. Myth 4: "Supplements and diet can fix everything" — lifestyle matters (smoking cessation, healthy weight) but does not replace a clinical workup. Myth 5: "If you've already had a child you can't be infertile" — secondary infertility is just as real as primary infertility and deserves the same investigation.

Information on preços de fertilização in vitro (fiv) em portugal on this site is triangulated from four families of official sources: (a) European epidemiological data published by the European IVF Monitoring Consortium (EIM) under ESHRE; (b) annual reports by the CNPMA, including success rates by centre and by technique; (c) clinical guidelines from the Portuguese DGS and protocols of the SNS; (d) international systematic reviews and guidelines — NICE Fertility Guideline NG156, the HFEA Code of Practice, ASRM practice committee opinions and the WHO infertility hub. We recommend validating specific claims directly in these sources and treating unsourced or testimonial-only claims with caution.

Geography matters in reproductive medicine. Over 80% of CNPMA-licensed centres cluster in the districts of Lisbon, Porto, Coimbra, Aveiro and Braga, with additional presence in Faro, Évora, Funchal and Ponta Delgada. For patients living outside these hubs, the monitoring logistics — scans and bloods every 2–3 days during stimulation — are one of the main practical variables to plan. Some clinics have agreements with imaging providers in peripheral cities to reduce travel. In the public sector, the SNS operates referral units per region: Lisbon (Maternidade Alfredo da Costa, Santa Maria, Garcia de Orta), Porto (Centro Materno-Infantil do Norte, São João), Coimbra (CHUC) and the Algarve (CHUA Faro). Waiting times range from 8 to 24 months across regions, which is why registering in more than one centre is worth considering when eligible.

According to the World Health Organization, the emotional burden of fertility treatment is comparable to that of cancer care. European longitudinal studies report depressive or anxious symptoms in 30–40% of patients during treatment, peaking between the second and fourth cycles. The ESHRE Psychology and Counselling Special Interest Group recommends integrated, non-optional psychological care — available inside the centre itself, without extra waiting lists. In Portugal, public centres have a clinical psychologist assigned to the fertility team; in private centres the offering varies. Seek this resource actively, especially before the second cycle: evidence shows better treatment adherence, lower drop-out and better overall experience when psychological support is structured from the start.